Moreover, the reduction in systemic low-grade inflammation and positive microbiome regulation may also lead to improvements in insulin sensitivity and insulin resistance, both hallmarks of T2DM [112,113,114]. The gene discussed is INS; the disease is type 2 diabetes mellitus.